GLP-1 weight-loss boom linked to surge in poison control calls
As the use of GLP-1 medications for weight loss surges, so do calls to U.S. poison control centers, according to a new study.
2 hours ago
0
1
Chemical Actions and Uses: News and Research on Glucagon-Like Peptide-1 Receptor Agonists
MeSH tree: D27.505.696.422.125
Will GLP-1s lead to fewer prescriptions for older adults?
As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...
7 hours ago
0
2
Obesity inequalities in England have widened since COVID-19—with steepest increases in new cases in young adults
A study by researchers from the University of Cambridge, the British Heart Foundation Data Science Center at Health Data Research UK and The George Institute for Global Health is the first to analyze obesity trends from 2019 ...
23 hours ago
0
4
New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...
Jun 24, 2026
1
25
'Food noise' discussion on social media helps define the term
With the rise of weight-loss drugs such as GLP-1 medications in recent years, the phrase "food noise" has taken off, particularly in conversations about health and wellness on social media. While thinking about food during ...
Jun 23, 2026
0
3
Beyond GLP-1s: The next chapter of obesity care
The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.
Jun 17, 2026
0
6
How the rise of weight-loss drugs could reshape food markets in the Global South
A new article published in Globalization and Health warns that the rapid rise of GLP-1 weight-loss drugs in high-income countries could have unintended consequences for food environments in low- and middle-income countries.
Jun 16, 2026
0
4
An economic case for teen weight-loss surgery
Metabolic and bariatric surgery for teens with severe obesity was found to be cost-effective over 10 years, according to a new analysis from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Network Open. ...
Jun 15, 2026
1
3
Clinical trials suggest GLP-1s may improve fertility in men with obesity
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve ...
Jun 15, 2026
0
5
More than half of those who stop GLP-1s restart within a year, study finds
People prescribed GLP-1 medications are more likely to start and stop than most people assume, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
Jun 14, 2026
0
4
